| Literature DB >> 26703594 |
Shudai Lin1,2,3, Li Zhang4,5,6,7, Wen Luo8,9,10, Xiquan Zhang11,12,13.
Abstract
Recently, an increasing number of studies on natural antisense transcripts have been reported, especially regarding their classification, temporal and spatial expression patterns, regulatory functions and mechanisms. It is well established that natural antisense transcripts are produced from the strand opposite to the strand encoding a protein. Despite the pivotal roles of natural antisense transcripts in regulating the expression of target genes, the transcriptional mechanisms initiated by antisense promoters (ASPs) remain unknown. To date, nearly all of the studies conducted on this topic have focused on the ASP of a single gene of interest, whereas no study has systematically analyzed the locations of ASPs in the genome, ASP activity, or factors influencing this activity. This review focuses on elaborating on and summarizing the characteristics of ASPs to extend our knowledge about the mechanisms of antisense transcript initiation.Entities:
Keywords: activity; antisense promoter; characteristics; influencing factors; location
Mesh:
Substances:
Year: 2015 PMID: 26703594 PMCID: PMC4730256 DOI: 10.3390/ijms17010009
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Characteristics of the locations of antisense promoters (ASPs). When an ASP (red reverse dotted arrow) and the sense promoter (SP) (black solid arrow) are located in the same gene (A); the ASP can be located at any position in the 5′-UTR, exons and introns or 3′-UTR. ASPs can also be located in genes upstream or downstream (gene B or C, respectively) of the SP gene (B); or an ASP may be located between two genes, with SP in the same region (green rectangle) (C). In the figure, “/ /” indicates other exons and introns.
Figure 2Schematic representation of the position of L1 ASPs in humans and mice. (A) The L1 5′-UTR (human) harbors an ASP (red reverse arrow) and a SP (black arrow) [36,37]; the mouse L1 ASP (red arrow showed in (B) is within ORF1 [37]. The G-C base rich (GC-rich) region (0–485 bp, black box) plays a role in the activity of the L1 ASP. There are 24 TSSs (transcription start sites) in purple arrow mapped to the opposite strand of the L1 5′-UTR. Interestingly, the L1 ASP functions as an alternative promoter, generating not only antisense transcripts, but also chimeric mRNAs [36]. ORF0 (yellow rectangle), a primate-specific open reading frame-0 located in 236–452 bp, not only contributes to the generation of ORF0-proximal exon fusion proteins but also enhances L1 mobility and there are 24 TSSs of various tissues located in 386–503 bp (purple bracket) [25]. The wright arrows means the transcriptional direction of ORF0, and the black dotted line and connected black boxes represent its transcript alternative splicing; (B) The mouse L1 ASP is located in ORF1, which includes a TATAA sequence at 2689 bp (orange arrow) and the ASP region with the highest activity from 2125 to 2823 bp (green frame) [37]. It has been demonstrated that RNA polymerase II (orange circle) and Dicer (blue circle) participate in the L1 ASP transcriptional initiation complex, with the latter playing a modest role in limiting native L1 retrotransposition. There are also different TSSs located in the L1 ASP, such as brain tissue-specific TSSs located at 2240–2250 bp and 2430–2440 bp (black reverse arrow); a kidney-specific TSS is located at 2320–2330 bp (black reverse arrow). The difference between the L1 ASPs of humans and mice is due to evolutionary events [3].
Figure 3The distribution of antisense transcript start regions (ATSRs). Here, we hypothesized that one or more ASPs are located in ATSRs. The pie chart shows the ATSR distribution per genomic element. The distribution was evaluated for RefSeq genes with at least three exons for which it was possible to unambiguously distinguish the first and last introns. Globally, the distribution among 2671 RefSeq genes indicated that 94.3% of 2830 RefSeq genes contain an ATSR [33]. More than 50% of the ASPs are located in exon 1, intron 1 and intron 2.
Information of different transcription factors (TFs) in uni- and bi-directional promoters.
| TATA-Less or TATA-Containing Promoters | TF Name | Location | Sequence (5′–3′) | Bidirectional Promoter | Unidirectional Promoter | Mechanism |
|---|---|---|---|---|---|---|
| TATA-box lacking promoters | INR | −3–+5 | YYANWYY | 25.30% [ | 30.80% [ | It can function independently, and together with the TATA box or DPE [ |
| BRE | −37–−32 | SSRCGCC | 16.50% [ | 11.10% [ | TFIIB–BRE interaction may play a dominant role in the assembly of the pre-initiation complex and transcription initiation [ | |
| CCAAT | −75–−80 | GGCCAATCT | 12.9% [ | 6.90% [ | Enhances the transcriptional rate [ | |
| DPE | +28–+32 | DSWYVY(T) | 46.65% [ | 50.60% [ | It can be recognized by TBP-associated factors (TAFs), such as TAF6 and TAF9 [ | |
| TATA-box containing promoters | Sp1 | Ubiquitously located near the TSS [ | GGGGCGG | / | / | Sp1 acts through its zinc finger domain at the carboxyl end to interact with GC rich sequences of downstream target genes [ |
| NF-κB | / | / | / | / | It binds to the DNA sequence: 5-GGGRNYYY-3 [ | |
| TATA | −25–−30 | TATAAA | 9% [ | 29% [ | TATA box and INR interact synergistically when they are separated by 25–30 bp [ | |
| CpGI | 5′-regions of housekeeping genes and many tissues-specific genes [ | size: 0.5–2 kb in length | 77% [ | 56% [ | Hypermethylation of a CpGI in the promoter region usually suppresses gene expression [ |
Information derived from Orekhova and Rubtsov (2013) [7], Lepoivre et al. (2013) [42], Hildebrandt et al. (1992) [43], Silverman et al. (1992) [44], Duart-Garcia and Braunschweig (2014) [45], Gazon et al. (2012) [56], Yoshida et al. (2008) [57], Xie et al. (2007) [58], Yang and Elnitski (2008) [59], Abe and Gemmell (2014) [64], Wierstra (2008) [66], Zanotto et al. (2008) [67], Arpin-André et al. (2014) [68], Bentley et al. (2004) [69], Kobayashi-Ishihara et al. (2012) [70], Tufarelli et al. (2013) [71], Liu et al. (2011) [72], Lin et al. (2007) [73], Li et al. (2011) [74], Weber et al. (2010) [75], Rao et al. (2013) [76] and Shu et al. (2006) [77]. (DNA fragment no less than 500 bp with a GC-content ≥55% and Obs/Exp value ≥0.60). R, N, and Y denote for any purine, any pyrimidine, and any nucleotide, respectively.